Literature DB >> 30229330

Carbon nanotubes and crystalline silica induce matrix remodeling and contraction by stimulating myofibroblast transformation in a three-dimensional culture of human pulmonary fibroblasts: role of dimension and rigidity.

Bridget Hindman1, Qiang Ma2.   

Abstract

Pulmonary fibrosis is a poorly understood pathologic condition. Carbon nanotubes (CNTs) are nanomaterials with potentials for broad applications. CNTs can induce pulmonary fibrosis in animals, a cause for concern for exposed workers and consumers. Given the large number of CNTs available on the market and the seemingly infinite number of ways these particles can be modified in ways that may affect toxicity, in vitro models that can be used to quickly and effectively investigate the relative fibrogenicity of CNTs are much needed. Here we analyzed the fibrogenic potentials of six CNTs of varying physical properties and crystalline silica using two- and three-dimensional (2D and 3D, respectively) in vitro models. WI38-VA13 human pulmonary fibroblasts were treated with CNTs or silica, with TGF-β1, a known inducer of fibroblast differentiation, as positive control. The cells were examined for fibrotic matrix alterations, including myofibroblast transformation, matrix remodeling, and matrix contraction. While all tested CNTs induced myofibroblast differentiation in 2D and 3D cultures, the 3D culture allowed the examination of myofibroblast clustering, collagen deposition and rearrangement, cell division, and matrix contraction in response to fibrogenic exposures, processes critical for fibrosis in vivo. At 1 µg/ml, MWCNTs elicit higher induction of myofibroblast differentiation and matrix remodeling than SWCNTs. Among MWCNTs, those with the highest and lowest aspect ratios produced the largest effects, which were comparable to those by TGF-β1 and higher than those by silica. Thus, the 3D collagen-based model enables the study of matrix fibrotic processes induced by CNTs and silica particles directly and effectively.

Entities:  

Keywords:  3D culture; CNT; Fibrosis; Matrix remodeling; Myofibroblast; Silica

Mesh:

Substances:

Year:  2018        PMID: 30229330     DOI: 10.1007/s00204-018-2306-9

Source DB:  PubMed          Journal:  Arch Toxicol        ISSN: 0340-5761            Impact factor:   5.153


  5 in total

1.  Modulating the Biomechanical Properties of Engineered Connective Tissues by Chitosan-Coated Multiwall Carbon Nanotubes.

Authors:  Naim Kittana; Mohyeddin Assali; Wolfram-Hubertus Zimmermann; Norman Liaw; Gabriela Leao Santos; Abdul Rehman; Susanne Lutz
Journal:  Int J Nanomedicine       Date:  2021-02-15

2.  Histopathology of the broad class of carbon nanotubes and nanofibers used or produced in U.S. facilities in a murine model.

Authors:  Kelly Fraser; Ann Hubbs; Naveena Yanamala; Robert R Mercer; Todd A Stueckle; Jake Jensen; Tracy Eye; Lori Battelli; Sidney Clingerman; Kara Fluharty; Tiana Dodd; Gary Casuccio; Kristin Bunker; Traci L Lersch; Michael L Kashon; Marlene Orandle; Matthew Dahm; Mary K Schubauer-Berigan; Vamsi Kodali; Aaron Erdely
Journal:  Part Fibre Toxicol       Date:  2021-12-20       Impact factor: 9.400

Review 3.  Scoping review and interpretation of myofascial pain/fibromyalgia syndrome: An attempt to assemble a medical puzzle.

Authors:  Shiloh Plaut
Journal:  PLoS One       Date:  2022-02-16       Impact factor: 3.240

Review 4.  Pulmonary Toxicity of Silica Linked to Its Micro- or Nanometric Particle Size and Crystal Structure: A Review.

Authors:  Vanessa Marques Da Silva; Manon Benjdir; Pierrick Montagne; Jean-Claude Pairon; Sophie Lanone; Pascal Andujar
Journal:  Nanomaterials (Basel)       Date:  2022-07-13       Impact factor: 5.719

5.  Gene Expression Profiling of Mono- and Co-Culture Models of the Respiratory Tract Exposed to Crystalline Quartz under Submerged and Air-Liquid Interface Conditions.

Authors:  Alexandra Friesen; Susanne Fritsch-Decker; Matthias Hufnagel; Sonja Mülhopt; Dieter Stapf; Carsten Weiss; Andrea Hartwig
Journal:  Int J Mol Sci       Date:  2022-07-14       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.